BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26982769)

  • 1. Polish activity within Orphanet Europe--state of art of database and services.
    Jezela-Stanek A; Karczmarewicz D; Chrzanowska KH; Krajewska-Walasek M
    Dev Period Med; 2015; 19(4):536-41. PubMed ID: 26982769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Orphanet and its consortium: where to find expert-validated information on rare diseases].
    Maiella S; Rath A; Angin C; Mousson F; Kremp O
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S3-8. PubMed ID: 23452769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Orphanet: a European database for rare diseases].
    Weinreich SS; Mangon R; Sikkens JJ; Teeuw ME; Cornel MC
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):518-9. PubMed ID: 18389888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How the EUCERD Joint Action supported initiatives on Rare Diseases.
    Lynn S; Hedley V; Atalaia A; Evangelista T; Bushby K;
    Eur J Med Genet; 2017 Mar; 60(3):185-189. PubMed ID: 28087401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare diseases in ICD11: making rare diseases visible in health information systems through appropriate coding.
    Aymé S; Bellet B; Rath A
    Orphanet J Rare Dis; 2015 Mar; 10():35. PubMed ID: 25887186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Practice Guidelines for Rare Diseases: The Orphanet Database.
    Pavan S; Rommel K; Mateo Marquina ME; Höhn S; Lanneau V; Rath A
    PLoS One; 2017; 12(1):e0170365. PubMed ID: 28099516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The national plan for orphan rare diseases: nearly 10 years on].
    Guillevin L
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S9-11. PubMed ID: 23452775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vision and challenges of a cartographic representation of expert medical centres for rare diseases.
    Storf H; Hartz T; Tegtbauer N; Pfeiffer W; Schmidtke J; Graessner H; Wagner T; Uckert F
    Stud Health Technol Inform; 2014; 205():677-81. PubMed ID: 25160272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National plans and strategies on rare diseases in Europe.
    Taruscio D; Vittozzi L; Stefanov R
    Adv Exp Med Biol; 2010; 686():475-91. PubMed ID: 20824461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).
    Federico A
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S12-7. PubMed ID: 23452765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare neurological diseases: a united approach is needed.
    The Lancet Neurology
    Lancet Neurol; 2011 Feb; 10(2):109. PubMed ID: 21256450
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rare metabolic diseases].
    Wendel U; Burgard P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1556-63. PubMed ID: 18026881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHIRE (Public Health Innovation and Research in Europe): methods, structures and evaluation.
    Barnhoorn F; McCarthy M; Devillé W; Alexanderson K; Voss M; Conceição C
    Eur J Public Health; 2013 Nov; 23 Suppl 2():6-11. PubMed ID: 24189789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [se-atlas - the health service information platform for people with rare diseases : Supporting research on medical care institutions and support groups].
    Haase J; Wagner TOF; Storf H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):503-509. PubMed ID: 28275836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inaugural conference - what stakes face rare diseases in the French health care system].
    Péton-Klein D
    Med Sci (Paris); 2014 Apr; 30 Spe(1):5-7. PubMed ID: 24755170
    [No Abstract]   [Full Text] [Related]  

  • 17. Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users.
    Rath A; Olry A; Dhombres F; Brandt MM; Urbero B; Ayme S
    Hum Mutat; 2012 May; 33(5):803-8. PubMed ID: 22422702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interoperability Architecture for a Paediatric Oncology European Reference Network.
    Nitzlnader M; Canete Nieto A; Ribelles AJ; Brunmair B; Ladenstein R; Schreier G
    Stud Health Technol Inform; 2016; 223():39-45. PubMed ID: 27139383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Tumors in Children: Progress Through Collaboration.
    Pappo AS; Furman WL; Schultz KA; Ferrari A; Helman L; Krailo MD
    J Clin Oncol; 2015 Sep; 33(27):3047-54. PubMed ID: 26304909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].
    Frank M; Eidt-Koch D; Aumann I; Reimann A; Wagner TO; Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1216-23. PubMed ID: 25209683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.